Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Expert Opinion on Therapeutic Targets|October 8, 2004
STAT proteins as novel targets for cancer drug discoveryJames TurksonExpert Opinion on Investigational Drugs|December 5, 2008
Targeting STAT3 in cancer: how successful are we?Peibin Yue, James TurksonThe Journal of Pharmacology and Experimental Therapeutics|January 27, 2010
Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant signal transducer and activator of transcription 3 and epidermal growth factor receptor or SrcSoumya Jaganathan, Peibin Yue, James TurksonCell Research|January 30, 2008
STAT3 as a target for inducing apoptosis in solid and hematological tumorsKhandaker Al Zaid Siddiquee, James TurksonThe Journal of Biological Chemistry|September 3, 2010
A cell-permeable Stat3 SH2 domain mimetic inhibits Stat3 activation and induces antitumor cell effects in vitroWei Zhao, Soumya Jaganathan, James TurksonNature Reviews. Drug Discovery|August 2, 2013
Therapeutic modulators of STAT signalling for human diseasesGabriella Miklossy, Tyvette S Hilliard, James TurksonThe EMBO Journal|July 3, 2002
Cytoplasmic transport of Stat3 by receptor-mediated endocytosisAndrea H Bild, James Turkson, Richard JoveNature Clinical Practice. Oncology|November 3, 2005
Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancerEric B Haura, James Turkson, Richard JoveExperimental Cell Research|May 31, 2011
The R(h)oads to Stat3: Stat3 activation by the Rho GTPasesLeda Raptis, Rozanne Arulanandam, Mulu Geletu, et al.Journal of Virology|January 15, 2005
Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replicationGulam Waris, James Turkson, Tarek Hassanein, et al.Pageof 9